If you can't explain the problem, the NHS won't know it should pay you
Every founder should be able to say in one sentence whose problem they're solving—so they get directed to the NHS person actually responsible for that issue, then asked if they'll pay for it. That's where healthcare entrepreneurship begins.
The video won't play here. Listen to the audio instead:
The argument · tap a timestamp to hear it
Half of all startups fail in their first year
James cites Y Combinator data: 50% of startups fail in year one, with the high-risk window lasting one to two years. He defines his accelerator work as specifically compressing this risk period—deploying knowledge, mentorship, and network access to push the high-risk curve down and forward, helping teams escape the most dangerous early years faster.
— JamesCo-founders usually find each other by accident, not design
James breaks down how startups actually form: one person spots a problem, then luck brings another person with complementary views and skills. The harder problem: solutions discovered by practitioners are often naturally misaligned with industry needs. When an industry receives the solution, its first questions are always the same—Is this a real problem? Do customers exist? Can it scale? What's the addressable market?
— JamesFirst explain whose problem you solve, then find who pays
James repeats this: every startup must articulate in one sentence which problem it solves—because then you know exactly who in the NHS owns it (perhaps a deputy chief nurse, a transformation director, or a CCG leader), and you get directed straight to that person. Only then do you ask: will you pay for this? That's when a real business model takes shape.
— JamesProcurement caution, not technical limits, slows NHS innovation
James explains why NHS innovation moves slowly: healthcare can't pause and redesign mid-cycle; any change requires solid evidence; procurement makers carry real accountability, not fashion risk. The NHS also lacks spare budget for non-essential products. Add near-zero interoperability across the health system, navigation friction for patients, and long CQC certification and regulatory cycles, and the innovation timeline stretches significantly.
— JamesHS separates building founders from scaling companies into two distinct programs
HS's solution: build and scale. Build targets individuals with ideas, early teams, and seed-funded companies—taking them from zero to a working tech company with customers and investment. Scale, in partnership with the Department for International Trade, exports UK's best health-tech globally and gives foreign entrants a soft landing—helping them navigate data protection, information governance, and adapt their business model to the NHS.
— JamesInvestment approval range between £10k and £2m sets an achievable first target
HS is surrounded by a pool of VCs and angels who can enter at any incubation stage. HS also partners deeply with reinsurer RGA, so teams can pitch directly to RGA's investment committee and apply for funds in the £10k–£2m band. This is a relatively clear funding path HS can unlock.
— JamesHS is recruiting data scientists to balance its doctor and business founders
The HS team itself blends a trauma orthopedist, serial entrepreneurs, an accelerator evaluation specialist, and a former company CFO. James ends with a direct call: most build-program applicants come from medicine or business backgrounds; what the team needs most is data scientists. Anyone ready to join a startup can talk to him and get matched directly into a build program.
— JamesIn their own words · checked verbatim
Y Combinator data says that 50 percent of startups will fail in year one
James2:33
my job running an accelerator running accelerators is to essentially make it less risky for startups in their initial phase of life
James2:33
you need to spot a problem you need to then by luck find someone else who thinks they spot the same problem with complementary skills you too will come together to form a startup to solve that problem
James3:33
every startup should be able to answer the questions what problems you solve because once you know exactly what problem it is you solve I can then direct you to the right person within healthcare whose problem that actually is
James4:34
healthcare is often looked at as slow to innovate particularly when you think about the NHS and the reason is is because you know we can't just stop what we're doing in healthcare and redesign something and start again
James5:34
nothing is interoperable with anything in healthcare there's lots of different programs that need lots of different things and there's specifically startups around solving the interoperability problem
James5:34
we also again work with our GA so you can see it front of their investment committee for anything between 10k and 2 million
James7:37
Figures
| Startup failure rate in year one | 50% | 2:33 |
| Total funding HS has helped startups raise | £30m | 1:32 |
| NHS pilot contracts achieved | 50 | 1:32 |
| London sites where solution was deployed | 348 | 1:32 |
Glossary
- CCG (Clinical Commissioning Group)
- The local NHS body responsible for purchasing and funding healthcare services in a region.
- CQC (Care Quality Commission)
- The UK's health and social care regulator; products and services require its certification before entering the NHS.
- SME (Scale-stage health-tech company)
- A health-tech firm with proven scale and traction, preparing to expand internationally through accelerator support.
How to listen
Doctors and engineers with healthcare backgrounds who want to start companies, and early-stage teams looking for co-founders or NHS sales channels.
Skip the opener and HS's institutional history; the core content starts at 2:33.